IR

IRLAB Therapeutics ABSTO IRLAB Therapeutics Stock Report

Last reporting period 30 Sep, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.254

Micro

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

Cash flow from operating activities CFO

-0.0049 B

Last period CFO ,SEK

100%

CFO has increased in 5 years


What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO ?

Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.

What is CFO of IRLAB Therapeutics ?

IRLAB Therapeutics`s CFO for the period ended 2024-09-30 is -0.0049 B SEK

View Full Company Analysis